Pharmaceutical composition for treating insomnia and application thereof

Abstract

The invention relates to a pharmaceutical composition for treating insomnia. The active ingredients of the composition comprise fludiazepam, chlorpromazine and Phenobarbital. The fludiazepam, chlorpromazine and Phenobarbital are combined to be used for treating the insomnia. The defects that the curative effect of single medication is poor and drug dependence of a patient is easily produced are overcome. The three medicines are combined to achieve a synergistic effect of enhancing insomnia resistance, and the clinical dosage of one or two medicines can be reduced, so that the toxicity reducingeffect is achieved.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition for treating insomnia and its application. Background technique [0002] Insomnia is the inability to fall asleep or stay asleep, resulting in a lack of sleep. Also known as sleep and sleep maintenance disorders, it is a common disease caused by various reasons such as difficulty in falling asleep, too short sleep depth or frequency, early awakening and insufficient sleep time or poor quality. Although insomnia is not a critical disease, it often affects the quality of life and hinders people's work, study and health. Long-term insomnia has brought great suffering to people and has become a public health problem more and more. [0003] Today, with the accelerated pace of society and intensified competition, the incidence of insomnia patients continues to rise. Insomnia has become a ubiquitous phenomenon and has become a hot research topi...

AI Technical Summary

Problems solved by technology

At present, the treatment of insomnia mainly focuses on the use of sleep aids, but the efficacy of a single sleep aid is poor, and patients are prone to drug resistance, so there is an urgent need to explore new pharmaceutical preparations for the treatment of insomnia